Mesa Laboratories (NASDAQ: MLAB) director adds stock via RSU vesting
Rhea-AI Filing Summary
Mesa Laboratories director R. Tony Tripeny reported the vesting and settlement of 2,784 Restricted Stock Units (RSUs) into 2,784 shares of common stock on August 15, 2026. The RSUs, each representing a contingent right to one common share, vested on that date, increasing his directly held common stock to 9,082 shares. The derivative RSU position was reduced to zero as a result of this exercise and conversion.
Positive
- None.
Negative
- None.
Insider Trade Summary
Net Buyer: 2,784 shares
Net Buy
2 txns
Insider
Tripeny R Tony
Role
Director
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Restricted Stock Units - 4 F1, F2, F3 | 2,784 | $0.00 | $0.00 |
| Exercise | Common Stock | 2,784 | $0.00 | $0.00 |
Holdings After Transaction:
Restricted Stock Units - 4 — 0 shares (Direct);
Common Stock — 9,082 shares (Direct)
Footnotes (3)
- F1. Each RSU represents a contingent right to receive one share of the Issuer's common stock
- F2. RSUs that vested on August 15, 2026
- F3. Not Applicable
Key Figures
RSUs exercised/converted: 2,784.0000 shares
Common shares acquired from RSUs: 2,784.0000 shares
Shares held after transaction: 9,082.0000 shares
+1 more
4 metrics
RSUs exercised/converted
2,784.0000 shares
Restricted Stock Units converted into common stock on August 15, 2026
Common shares acquired from RSUs
2,784.0000 shares
Common stock received upon RSU vesting and conversion on August 15, 2026
Shares held after transaction
9,082.0000 shares
Total directly owned Mesa Laboratories common stock following the RSU conversion
Reported transaction price per share
0.0000
Per-share value reported for both RSU derivative and resulting common stock entries
Key Terms
Restricted Stock Units, derivative security, contingent right
3 terms
Restricted Stock Units financial
"Each RSU represents a contingent right to receive one share"
Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.
derivative security financial
"Exercise or conversion of derivative security"
A derivative security is a financial contract whose value comes from the price or performance of something else, such as a stock, bond, commodity, or market index. For investors it acts like an insurance policy or a wager: it can be used to protect against losses, lock in prices, or amplify gains and losses, so it can change a portfolio’s risk and potential return without owning the underlying asset directly.
contingent right financial
"represents a contingent right to receive one share"
FAQ
What insider transaction did R. Tony Tripeny report for MLAB on August 15, 2026?
R. Tony Tripeny reported the vesting and conversion of 2,784 RSUs into 2,784 shares of Mesa Laboratories common stock on August 15, 2026, reflecting a routine equity award settlement rather than an open-market purchase or sale.
What happened to the 2,784 Restricted Stock Units reported by MLAB director Tripeny?
The 2,784 Restricted Stock Units vested on August 15, 2026 and were exercised/converted into an equal number of Mesa Laboratories common shares. Following this conversion, the reported RSU derivative position was reduced to zero.
Were the MLAB Form 4 transactions by R. Tony Tripeny market purchases or sales?
The Form 4 reports an exercise/conversion of RSUs into common stock, not open-market purchases or sales. The derivative RSUs were disposed as a derivative position, and 2,784 common shares were acquired directly at a reported price of $0.00 per share.
What does each RSU reported by MLAB director Tripeny represent?
Each RSU reported represents a contingent right to receive one share of Mesa Laboratories common stock. Upon vesting on August 15, 2026, these RSUs were settled in shares, delivering 2,784 common shares to the reporting person.
AI-generated analysis. How Rhea-AI works. Not financial advice.
